ADMA BIOLOGICS, INC.
Ticker: 1368514
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 124.40+8.7% | 114.49-14.7% | 134.22+10.0% | 121.98+6.3% | 114.80-4.2% | 119.84+11.8% | 107.19+30.9% | 81.88 |
| Total Income | 124.40+8.7% | 114.49-14.7% | 134.22+10.0% | 121.98+6.3% | 114.80-4.2% | 119.84+11.8% | 107.19+30.9% | 81.88 |
| EXPENSES | ||||||||
| Expenditure | 71.95+28.0% | 56.22-32.4% | 83.21+5.1% | 79.19-0.9% | 79.92-0.3% | 80.20+18.0% | 67.99+13.2% | 60.05 |
| Tax | 12.42+5.3% | 11.80+6.4% | 11.09+88.6% | 5.88-10.2% | 6.55+679.8% | 0.84-77.8% | 3.79+531.7% | 0.60 |
| PROFIT | ||||||||
| PBT | 50.24-12.1% | 57.13+20.2% | 47.52+18.5% | 40.10+19.9% | 33.45-9.0% | 36.75+2.5% | 35.85+94.8% | 18.40 |
| Net Profit | 37.82-16.6% | 45.33+24.4% | 36.43+6.5% | 34.22+27.2% | 26.90-25.1% | 35.91+12.0% | 32.06+80.0% | 17.81 |
| KEY METRICS | ||||||||
| OPM % | 42.16%-8.74pp | 50.90%+12.89pp | 38.01%+2.92pp | 35.09%+4.70pp | 30.38%-2.69pp | 33.08%-3.49pp | 36.57%+9.92pp | 26.65% |
| NPM % | 30.41%-9.19pp | 39.59%+12.45pp | 27.14%-0.91pp | 28.05%+4.62pp | 23.43%-6.53pp | 29.96%+0.05pp | 29.91%+8.16pp | 21.75% |
| EPS | 0.17-10.5% | 0.19+26.7% | 0.15+7.1% | 0.14+27.3% | 0.11-26.7% | 0.15+7.1% | 0.14+75.0% | 0.08 |
Corporate Events
Board MeetingADMA
20262Jun
Board Meeting
Annual Meeting of Stockholders to vote on the election of tw…
SEC Filing ↗